Join our mailing list to be the first to hear about the 2023 summit.
The 2022 summit included talks from these experts:
Our initiative to build a more accessible future is made possible by the support of gracious companies with like-minded goals.
Become a sponsor of the 2023 Technology in Psychiatry Summit to help us further our mission to close the gaps between study and practice in mental health care.
Contact us now to learn more about this exciting opportunity to support the intersection of mental health and digital technologies.
We are grateful to the organizations who supported the 2022 summit.
We are also continually grateful to our past sponsors.
If you are interested in sponsoring the 2023 Technology in Psychiatry Summit, contact us today.
The event included an exciting lineup of esteemed keynotes and symposium panelists from around the world, converging to discuss the most important issues facing technology use in psychiatry, including novel therapies, improving accessibility, and adapting new frameworks for digital implementation. The summit round out with data blitz talks.
The 2021 keynote speakers included Dina Katabi, PhD, Massachusetts Institute of Technology, Ziad Obermeyer, MD, MPhil, Berkeley School of Public Health, Tom Sequist, MD, MPH, Mass General Brigham, Nora Volkow, MD, National Institute on Drug Abuse, and Miranda Wolpert, MBE, Wellcome Trust.
The theme of the 2020 conference was “Molecules to Mobile Phones: From Crisis to Opportunity,” focusing on the translational gap between findings in basic neuroscience to scalable and applied digital technology. We also examined how these technologies and neuroscience tools aided research and treatment during the recent global crises, and look at understanding the equity and ethics of these methods.
With keynote addresses, interactive panel discussions, technology demonstrations, and a virtual poster session, attendees examined the evolving state of global mental health efforts, cutting-edge trends in neurosciences, and new technologies and analytical tools that are cross-cutting traditionally separate disciplines to help address some of the world’s most challenging mental health problems.
Keynote speakers included Patricia Areán, PhD, Dan Gebremedhin, MD, Joshua A. Gordon, MD, PhD, Christine Grady, RN, PhD, Rana el Kaliouby, PhD, and Sendhil Mullainathan, PhD.
As research around digital psychiatry rapidly expands, it has become evident that there remains a vast potential for the application of technology across clinical populations. The 2019 summit focused on understanding how the application of technology varies among children, adolescents, young adults, and older adults. The conference further explored how technology can enhance care in major neuropsychiatric disorders such as autism and dementia. For the first time, the meeting also invited panel proposals from researchers around the world. The theme of the 2019 summit was, “The Future of Mental Health Across the Life Span.”
2019 keynote speakers were Molly Coye, MD, MPH, AVIA, Saul Levin, MD, MPA, FRCP-E, American Psychiatric Association, and Wendy Nilsen, PhD, National Science Foundation.
The theme of the 2018 Technology in Psychiatry Summit was “Closing Gaps in Translation.” Lectures and panels covered the topic in the sense of using technology and pervasive sensing approaches to advance the detailed cross-species study of behavior in order to help bridge the human-nonhuman translational gap, as well as applying these approaches to improve mental health in under-resourced areas both globally and in the U.S.
Keynote speakers included Michelle A. Williams, SM, ScD, Harvard T.H. Chan School of Public Health, Alex “Sandy” Pentland, PhD, MIT Connection Science and Human Dynamics Labs, and Bruce Cuthbert, PhD, NIMH Research Domain Criteria.
The 2017 Technology in Psychiatry Summit was a first of its kind event targeted at bringing together the nation’s top technology and mental health experts to build on the promise of technology in the diagnosis and delivery of mental health care. Among the who’s who of presenters were Tom Insel, MD, former NIMH director, Ken Duckworth, MD, of Blue Cross Blue Shield of Massachusetts, Roz Picard, ScD, of the Affective Computing Research Group at MIT, and Sarah Lenz Lock, JD, of the AARP.
